




Searching News Database: Lupin Pharmaceuticals
HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
HSMN NewsFeed - 27 Aug 2018
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
Tris Pharma Announces Hiring of New Vice President of Quality & Compliance
HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
HSMN NewsFeed - 22 Feb 2013
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
Lupin Receives FDA Approval for New Drug Application for SUPRAX(R) Oral Suspension, 500 mg/5mL
HSMN NewsFeed - 12 Apr 2007
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension
Additional items found! 4

Members Archive contains
4 additional stories matching:
Lupin Pharmaceuticals
(Password required)
Lupin Pharmaceuticals
(Password required)